Company intelligence / Profile preview

InCor

Hyderabad, Telangana, Indiaincor.in ↗
Ownership
Private
Employees
~2000
Development stage
Other
01

Overview

INCOR is a diversified Indian conglomerate with a significant presence in the healthcare and life sciences sectors. Headquartered in Hyderabad, the company operates a chain of multi-specialty hospitals under the OMNI Hospitals brand and has expanded into the pharmaceutical industry through its subsidiaries, INCOR Renovis Pharma and Incor Lifesciences. INCOR Renovis, a joint venture with Renovis Labs, focuses on developing cost-effective and "green" manufacturing technologies for Active Pharmaceutical Ingredients (APIs) and intermediates using directed evolution and microbiology platforms. The group is committed to making India self-reliant in medicine manufacturing while reducing the environmental impact of pharmaceutical production through automation and innovative chemical-biological solutions.

Therapeutic areas
NephrologyOtherCardiovascularGastroenterologyOncology
Modalities
Small moleculeBiologicPeptidesProtein
Industry
Biotech
02

Drug pipeline

1 asset

didodecyl-methotrexate

Preclinical
03

Partnerships

Renovis LabsDynex (Quantum-as-a-Service)Howard University

Beyond the preview

Go deeper on InCor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on InCor.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call